UNSPSC 51392002: Adibendan

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392002

Definition

This classification denotes a phosphodiesterase inhibitor with the molecular formula C16H14N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E87N3L27KX, chemically known as 5,7-dihydro-7,7-dimethyl-2-(4-pyridyl)pyrrolo(2,3-f)benzimidazol-6(3h)-one but generally known as adibendan, which bears US NIH Compound Identifier 65867. European Medicines Agency schedules Adibendan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05268MIG.

Read the full definition

The term ADIBENDAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). ADIBENDAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adibendan under HS 29337900 and SITC 51561. As of Q4 2014, ADIBENDAN remains the US FDA Preferred Term for this commodity. Adibendan bears US NLM identifiers UMLS ID C0050840 and NCI Concept Code C74350. SMILES: O=C1NC2C(C1(C)C)CC1[NH]C(NC1C2)C1CCNCC1.

About UNSPSC 51392002

UNSPSC 51392002 Adibendan is a Commodity code covering pharmaceutical products used in emergency response and public health interventions, specifically naloxone (an opioid antagonist) and drug deactivation systems procured by state and local health authorities. Seminole County, Florida recently solicited these products through an IFB to support community health initiatives, demonstrating that governments under this code purchase pharmaceutical supplies and complementary systems for overdose prevention and substance abuse management. The issuing body mix is limited in recent activity to county-level health departments and public health agencies seeking to build emergency response capacity and community wellness programs. Vendors must meet standard state and local compliance requirements including drug-free workplace certification, E-Verify enrollment, workers' compensation and commercial general liability insurance, and a three-month probationary period; Seminole County's procurement includes a potential FEMA funding component, introducing federal compliance obligations around environmental regulations and audit rights.

Seminole County, Florida represents the primary recent activity under this code. The IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract terms included a two-year initial period with a one-year renewal option and required vendors to provide unit-cost pricing and absorb all shipping and delivery expenses in their bids. Beyond the Seminole County opportunity, the source shows no additional recent state or local solicitations under this code, limiting visibility into broader geographic spread or activity patterns across other jurisdictions.

Quick answers

What is UNSPSC 51392002?

UNSPSC 51392002 is Adibendan, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392002?

UNSPSC 51392002 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392002

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code